Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Poniard Pharmaceuticals (PARD)
OTHER OTC:PARD
Holding PARD?
Track your performance easily
PARD Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.31 - $0.31
Previous Close$0.31
Volume41.00
Average Volume (3M)N/A
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)$1.98M
Total Debt (Recent Filing)$1.64M
Price to Earnings (P/E)―
Beta22.94
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume0
30 Day Avg. VolumeN/A
Standard Deviation13.61
R-Squared0.03
Alpha2.43
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda0.00
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
―
Mutual Funds
<0.01% Other Institutional Investors
100.00% Public Companies and
Individual Investors
PARD FAQ
What was Poniard Pharmaceuticals’s price range in the past 12 months?
Poniard Pharmaceuticals lowest stock price was $0.31 and its highest was $0.31 in the past 12 months.
What is Poniard Pharmaceuticals’s market cap?
Currently, no data Available
When is Poniard Pharmaceuticals’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Poniard Pharmaceuticals’s earnings last quarter?
Currently, no data Available
Is Poniard Pharmaceuticals overvalued?
According to Wall Street analysts Poniard Pharmaceuticals’s price is currently Overvalued.
Does Poniard Pharmaceuticals pay dividends?
Poniard Pharmaceuticals does not currently pay dividends.
What is Poniard Pharmaceuticals’s EPS estimate?
Poniard Pharmaceuticals’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Poniard Pharmaceuticals have?
Poniard Pharmaceuticals has 1,499,000 shares outstanding.
What happened to Poniard Pharmaceuticals’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Poniard Pharmaceuticals?
Currently, no hedge funds are holding shares in PARD
---
Company Description
Poniard Pharmaceuticals
Poniard Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on the development and commercialization of oncology products. The company is currently focusing on developing picoplatin, a new and differentiated platinum-based chemotherapeutic agent that is used in the clinical development for multiple cancer indications, treatment combinations, and by different routes of administration. The company was founded in 1984 and is headquartered in Seattle, WA.
---
Technical Analysis
---